These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Enfuvirtide: patient acceptance and strategies for managing injection-site reactions. Rice C; Wilantewicz H AIDS Read; 2006 Sep; 16(9):470-4, 490-1. PubMed ID: 17024766 [TBL] [Abstract][Full Text] [Related]
27. T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen. Lalezari JP; Bellos NC; Sathasivam K; Richmond GJ; Cohen CJ; Myers RA; Henry DH; Raskino C; Melby T; Murchison H; Zhang Y; Spence R; Greenberg ML; Demasi RA; Miralles GD; J Infect Dis; 2005 Apr; 191(7):1155-63. PubMed ID: 15747252 [TBL] [Abstract][Full Text] [Related]
28. Switching from a toxicity-causing antiretroviral to enfuvirtide in patients with HIV: the SWITCH TOX study. Streinu-Cercel A; de Gorgolas M; Müller M; Portilla J; Rugina S; Böcher W; Staszewski S; Pulik P; Rowell L; Salgo M; Stoll M HIV Clin Trials; 2008; 9(6):375-86. PubMed ID: 19203903 [TBL] [Abstract][Full Text] [Related]
29. T-20 being called "miraculous". AIDS Patient Care STDS; 2002 Sep; 16(9):462. PubMed ID: 12412581 [No Abstract] [Full Text] [Related]
30. A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide. Beatty G; Hunt P; Smith A; Hoh R; Huang W; Martin J; Deeks SG Antivir Ther; 2006; 11(3):315-9. PubMed ID: 16759047 [TBL] [Abstract][Full Text] [Related]
31. T-1249 development suspended. Huff B GMHC Treat Issues; 2003 Dec; 17(12):6. PubMed ID: 15011643 [No Abstract] [Full Text] [Related]
32. [Enfuvirtide. Two injections per day for HIV]. Taéron C Rev Infirm; 2004 Oct; (104):35-6. PubMed ID: 15581312 [No Abstract] [Full Text] [Related]
33. An open-label safety study of enfuvirtide injection with a needle-free injection device or needle/syringe: the Biojector 2000 Open-label Safety Study (BOSS). Lalezari JP; Saag M; Walworth C; Larson P AIDS Res Hum Retroviruses; 2008 Jun; 24(6):805-13. PubMed ID: 18507525 [TBL] [Abstract][Full Text] [Related]
34. Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerability. Belperio PS; Mole LA; Halloran J; Boothroyd DB; Thomas IC; Backus LI Ann Pharmacother; 2008 Nov; 42(11):1573-80. PubMed ID: 18940919 [TBL] [Abstract][Full Text] [Related]
35. Interaction between enfuvirtide, an injectable fusion inhibitor, and niacin in an HIV-infected patient. Oates E; Dzintars K Ann Pharmacother; 2010 Dec; 44(12):2014-7. PubMed ID: 21045170 [TBL] [Abstract][Full Text] [Related]
36. T-20: entirely new antiretroviral. James JS AIDS Treat News; 1997 Sep; (No 279):5-6. PubMed ID: 11364691 [TBL] [Abstract][Full Text] [Related]
37. [Fusion inhibitors. One year therapy with T-20--initial evaluation]. Goebel FD MMW Fortschr Med; 2004 Apr; 146 Spec No 1():42-3. PubMed ID: 15373046 [No Abstract] [Full Text] [Related]
38. Initiation of therapy with a subcutaneously administered antiretroviral in treatment-experienced HIV-infected patients: understanding physician and patient perspectives. Horne R; Cooper V; Fisher M AIDS Care; 2008 Oct; 20(9):1029-38. PubMed ID: 18825512 [TBL] [Abstract][Full Text] [Related]
39. Impact of education and support on the tolerability and quality of life in a cohort of HIV-1 infected patients treated with enfuvirtide (SURCOUF Study). Allavena C; Prazuck T; Reliquet V; Verdon R; Perré P; Le Moal G; Billaud E; Raffi F J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):187-92. PubMed ID: 18599881 [TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients. Wiznia A; Church J; Emmanuel P; Eppes S; Rowell L; Evans C; Bertasso A; Pediatr Infect Dis J; 2007 Sep; 26(9):799-805. PubMed ID: 17721374 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]